EUVIMEDEUVIMED entdecken
Multizentrische Studie

Impact of Clinical Pharmacist Practitioner Management of Chronic Obstructive Pulmonary Disease in the Ambulatory Care Setting

Alexa M Haddon iD, Kylee R Gross, Cassandra J Mozes

Journal of Pharmacy Practice · 2024

DOI: 10.1177/08971900221150286 ↗

Kurz gefasst

Multizentrische Studie in der Zeitschrift Journal of Pharmacy Practice, 2024. Verfasst von Alexa M Haddon und 2 weiteren Autor:innen. Beteiligte Einrichtung: Pharmacy Department, Erie VA Medical Center, Erie, PA, USA. Hauptthemen laut MEDLINE: Adrenal Cortex Hormones, Pulmonary Disease, Chronic Obstructive. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 9 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objectives

To evaluate the impact of clinical pharmacist practitioner (CPP) management on potentially inappropriate use of inhaled corticosteroids (ICS) in the ambulatory care setting.

Design

Multicenter, prospective quality assurance/improvement (QA/QI) project.

Setting

Erie Veterans Affairs Medical Center (VAMC) and surrounding Ashtabula, Crawford, and Venango County Community-Based Outpatient Clinics (CBOCs).

Participants

Thirty-five participants with chronic obstructive pulmonary disease (COPD) who met inclusion criteria were included in the project.

Interventions

Participants were contacted to schedule an initial sixty-minute telephone visit with a CPP. Exacerbation history, rescue inhaler use, and symptom burden were assessed using the COPD Assessment Test (CAT) and Modified Medical Research Counsel Breathlessness Scale (mMRC) scales. Medication regimens were optimized based on guideline recommendations with an emphasis on appropriate use of ICS. Participants were scheduled for follow-up telephone visits with the CPP every 4 weeks. Main Outcome Measures: The primary project outcome was potentially inappropriate use of ICS without a long-acting muscarinic antagonist (LAMA)/long-acting beta agonist (LABA). Secondary project outcomes included ICS de-escalation, vaccinations, and smoking cessation.

Results

The primary outcome of reducing use of ICS without a LAMA/LABA was achieved in thirty-one (88.6%) participants. ICS de-escalation was achieved in twenty-three (65.7%) participants. Rates of recommended vaccinations and smoking cessation with nicotine replacement therapy increased as a result of pharmacist intervention.

Conclusion

Pharmacist management of COPD in the ambulatory care setting was associated with a decrease in potentially inappropriate use of ICS and an increase in preventative care measures.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Adrenal Cortex HormonesPulmonary Disease, Chronic ObstructiveAgedFemaleHumansMaleMiddle AgedAdministration, InhalationAmbulatory CarePharmacistsProfessional RoleProspective Studies

Stichwörter der Autor:innen

ambulatory carechronic obstructive pulmonary diseasede-escalationinhaled corticosteroidspharmacist

Substanzen

Adrenal Cortex Hormones

Autor:innen und Institutionen

  • Pharmacy Department, Erie VA Medical Center, Erie, PA, USA.
  • Pharmacy Department, Chillicothe VA Medical Center, Chillicothe, OH, USA.

ORCID-Profile: Alexa M Haddon

Zitieren

APA

Haddon, A. M., Gross, K. R., & Mozes, C. J. (2024). Impact of Clinical Pharmacist Practitioner Management of Chronic Obstructive Pulmonary Disease in the Ambulatory Care Setting. Journal of Pharmacy Practice. https://doi.org/10.1177/08971900221150286

Vancouver

Haddon AM, Gross KR, Mozes CJ. Impact of Clinical Pharmacist Practitioner Management of Chronic Obstructive Pulmonary Disease in the Ambulatory Care Setting. Journal of Pharmacy Practice. 2024. doi:10.1177/08971900221150286

BibTeX
@article{Haddon2024,
  author = {Haddon, Alexa M and Gross, Kylee R and Mozes, Cassandra J},
  title = {Impact of Clinical Pharmacist Practitioner Management of Chronic Obstructive Pulmonary Disease in the Ambulatory Care Setting},
  journal = {Journal of Pharmacy Practice},
  year = {2024},
  doi = {10.1177/08971900221150286}
}
Kostenlos starten →